000 | 01987 a2200553 4500 | ||
---|---|---|---|
005 | 20250514210225.0 | ||
264 | 0 | _c20050428 | |
008 | 200504s 0 0 eng d | ||
022 | _a1542-0752 | ||
024 | 7 |
_a10.1002/bdra.20085 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOkada, Akinobu | |
245 | 0 | 0 |
_aPolycomb homologs are involved in teratogenicity of valproic acid in mice. _h[electronic resource] |
260 |
_bBirth defects research. Part A, Clinical and molecular teratology _cNov 2004 |
||
300 |
_a870-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAbnormalities, Drug-Induced _xetiology |
650 | 0 | 4 |
_aAmides _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
650 | 0 | 4 |
_aBone and Bones _xabnormalities |
650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
650 | 0 | 4 |
_aEmbryo, Mammalian _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Developmental |
650 | 0 | 4 | _aGene Silencing |
650 | 0 | 4 | _aHistone-Lysine N-Methyltransferase |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMyeloid-Lymphoid Leukemia Protein |
650 | 0 | 4 | _aPolycomb Repressive Complex 1 |
650 | 0 | 4 | _aPolycomb-Group Proteins |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aProto-Oncogenes _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aRepressor Proteins _xgenetics |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aTranscription Factors _xgenetics |
650 | 0 | 4 |
_aValproic Acid _xadministration & dosage |
650 | 0 | 4 | _aZinc Fingers |
700 | 1 | _aAoki, Yoshinobu | |
700 | 1 | _aKushima, Kiyoshi | |
700 | 1 | _aKurihara, Hiroshi | |
700 | 1 | _aBialer, Meir | |
700 | 1 | _aFujiwara, Michio | |
773 | 0 |
_tBirth defects research. Part A, Clinical and molecular teratology _gvol. 70 _gno. 11 _gp. 870-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/bdra.20085 _zAvailable from publisher's website |
999 |
_c15211586 _d15211586 |